(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CASPEROME BIOAVAILABLE BOSWELLIA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

CASPEROME BIOAVAILABLE BOSWELLIA

ST13

US500000079115164

Class

5, 42

Filing

79115164

Registration

4296899

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

45

Latest update

07/14/2024

Trademark type

Combined

Nice classes

5, 42

Filing date

05/21/2012

Registration date

03/05/2013

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/22/2023

Last transaction

09/22/2023

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

3

Owner type

03

Owner location

MILANO, IT

Examiner

TURNER, JASON

Law office

L80

Mark description

The mark consists of a figurative trademark consisting in the wording "CASPEROME" and, on a new line, "BIOAVAILABLE BOSWELLIA", in special uppercase letters; the first six letters of the first word, which size is greater than that of the other two words, are thicker than the remaining letters; a horizontal line appears between the two wordings, which line is broken right under the letters "OME" of the first word, wherein a curve line appears.

Holders and representatives

Holders

INDENA SPA
INDENA SPA

Representatives

STEWART J. BELLUS COLLARD & ROE, P.C.

Technical classification

Nice Classes

Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Medicinal plant extracts for pharmaceutical usefor the treatment of inflammationfor the treatment of immune system diseasesrespiratory system diseasescentral nervous system diseases and for the treatment of skin diseases; medicinal plant extracts for use as nutritional supplementsall made in whole or substantial part of boswellia

Class 42

Scientific research in the chemicalpharmaceuticalhygienic and beauty care fields

Publications

History of USPTO decisions and trademark events.

45 publications found

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

07/14/2024

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

06/20/2024

INPC

INVALIDATION PROCESSED

06/20/2024

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

06/14/2024

C71T

CANCELLED SECTION 71

09/22/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

05/27/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

05/14/2023

RNWL

INTERNATIONAL REGISTRATION RENEWED

06/09/2022

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/01/2022

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

03/05/2022

NREP

NEW REPRESENTATIVE AT IB RECEIVED

10/27/2021

NREP

NEW REPRESENTATIVE AT IB RECEIVED

07/17/2021

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

02/28/2020

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

01/10/2020

INPC

INVALIDATION PROCESSED

01/10/2020

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

12/11/2019

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

04/11/2019

71.P

REGISTERED - PARTIAL SEC 71 ACCEPTED

04/11/2019

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/02/2019

ES71

TEAS SECTION 71 RECEIVED

03/22/2019

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

08/24/2013

FICS

FINAL DISPOSITION NOTICE SENT TO IB

08/07/2013

FIMP

FINAL DISPOSITION PROCESSED

08/07/2013

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

06/05/2013

R.PR

REGISTERED-PRINCIPAL REGISTER

03/05/2013

GPNX

NOTIFICATION PROCESSED BY IB

01/18/2013

PUBO

PUBLISHED FOR OPPOSITION

12/18/2012

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

11/28/2012

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

11/28/2012

NPUB

NOTICE OF PUBLICATION

11/28/2012

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

11/15/2012

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/05/2012

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/03/2012

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/03/2012

ALIE

ASSIGNED TO LIE

10/26/2012

RFNT

REFUSAL PROCESSED BY IB

10/17/2012

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/15/2012

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

09/21/2012

RFRR

REFUSAL PROCESSED BY MPU

09/21/2012

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

09/21/2012

CNRT

NON-FINAL ACTION WRITTEN

09/20/2012

DOCK

ASSIGNED TO EXAMINER

09/11/2012

MAFR

APPLICATION FILING RECEIPT MAILED

08/11/2012

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/07/2012

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

08/02/2012

Continuous trademark protection

Get notified about every new filing that threatens CASPEROME BIOAVAILABLE BOSWELLIA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.